Protalix BioTherapeutics, Inc.
PLXNYSECIK 1006281HealthcareFiscal year ends Dec 31
Reports and events: 397 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1211:09 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-094444 |
| 2026-08-1210:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-094433 |
| 2026-06-2520:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-077790 |
| 2026-05-2111:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-064850 |
| 2026-05-1311:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-059756 |
| 2026-05-1310:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059749 |
| 2026-04-3020:30 ET | DEF 14A | Proxy statementPeriod 2026-06-25 | 0001104659-26-053016 |
| 2026-03-1811:12 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-029858 |
| 2026-03-1810:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-029846 |
| 2026-03-0911:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-024975 |
| 2026-02-1122:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-013498 |
| 2026-01-3015:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-008410 |
| 2026-01-0511:56 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-000393 |
| 2025-11-1311:58 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-110824 |
| 2025-11-1311:54 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-110821 |
| 2025-11-0321:44 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-105594 |
| 2025-10-1712:08 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-100264 |
| 2025-08-2220:39 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-081924 |
| 2025-08-1411:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011471 |
| 2025-08-1410:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011468 |
| 2025-08-0120:30 ET | 8-K | 8.01 Other events | 0001558370-25-009989 |
| 2025-07-2113:27 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-25-009308 |
| 2025-06-2620:30 ET | 8-K | 5.07 Shareholder vote results | 0001558370-25-008922 |
| 2025-05-0911:04 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007063 |
| 2025-05-0910:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007060 |
| 2025-04-3020:30 ET | DEF 14A | Proxy statementPeriod 2025-06-26 | 0001558370-25-006010 |
| 2025-04-2320:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-25-005275 |
| 2025-03-1721:19 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-003143 |
| 2025-03-1711:18 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-003039 |
| 2025-03-1710:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-003036 |
| 2024-12-3121:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001558370-24-016505 |
| 2024-12-2312:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-016445 |
| 2024-11-1412:03 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015612 |
| 2024-11-1411:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-015608 |
| 2024-10-2512:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-013664 |
| 2024-08-1411:02 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-012134 |
| 2024-08-1410:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-012133 |
| 2024-06-2821:32 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-24-009567 |
| 2024-05-1011:20 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007695 |
| 2024-05-1010:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-007692 |
| 2024-04-2920:30 ET | DEF 14A | Proxy statementPeriod 2024-06-27 | 0001104659-24-054084 |
| 2024-03-1411:03 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-003161 |
| 2024-03-1410:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-003160 |
| 2023-12-2611:56 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-020006 |
| 2023-11-0612:50 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-017664 |
| 2023-11-0612:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-017657 |
| 2023-09-1210:58 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-23-015635 |
| 2023-08-0711:02 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-013483 |
| 2023-08-0710:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-013481 |
| 2023-07-1320:41 ET | 8-K | 5.07 Shareholder vote results | 0001558370-23-011868 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.